Revenue
2011
2012
2013
2014
2015
2016
2017
2018
Modular Medical, Inc. (MODD)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $20.0M | $14.7M | $12.9M | $9.1M | $7.7M | $4.1M | $3.0M | $1.9M | $332,642 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $27.6M | $19.0M | $17.5M | $13.9M | $14.9M | $7.3M | $5.3M | $2.6M | $666,164 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$27.6M | −$19.0M | −$17.5M | −$13.9M | −$14.9M | −$7.3M | −$5.3M | −$2.6M | −$666,164 | −$91,051 | −$13,163 | −$16,115 | −$10,772 | −$10,920 | −$9,513 | −$9,174 | — | — | — | — | — | — | — | — | — | — | — |
| EBITDAderived | −$25.9M | −$18.0M | −$17.1M | −$13.7M | −$14.8M | −$7.2M | −$5.3M | −$2.6M | −$664,303 | — | — | — | −$10,772 | −$10,920 | −$9,513 | −$9,174 | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$28.2M | −$18.8M | −$17.5M | −$13.9M | −$18.6M | −$7.4M | −$5.3M | −$2.5M | −$659,246 | −$106,559 | −$31,084 | −$30,994 | −$22,794 | −$20,790 | −$17,492 | −$9,174 | −$7,668 | −$9,400 | −$6,716 | −$6,482 | −$8,906 | −$14,289 | −$6,207 | −$3,945 | −$26,635 | −$32,303 | −$6,828 |
| Basic EPSper diluted share | -$12.36 | -$15.26 | -$0.78 | -$1.15 | -$2.74 | -$0.40 | -$0.30 | -$0.15 | -$0.05 | -$0.06 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$12.36 | -$15.26 | -$0.78 | -$1.15 | -$2.74 | -$0.40 | -$0.30 | -$0.15 | -$0.05 | -$0.06 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 20, 2025Form 4 | MANCHESTER MANAGEMENT PR, LLC +5Other | BuyCommon Stock, par value $0.001 per share | 156.3K | $1.92 | $300.0K | 422.0K |
| Mar 20, 2025Form 4 | MANCHESTER MANAGEMENT PR, LLC +5Other | BuyCommon Stock, par value $0.001 per share · indirect | 520.8K | $1.92 | $1000.0K | 3.81M |
| Dec 3, 2024Form 4 | MANCHESTER MANAGEMENT PR, LLC +5TenPercentOwner,Other | BuyCommon Stock, par value $0.001 per share | 21.0K | $1.68 | $35.3K | 265.8K |
| Nov 27, 2024Form 4 | JEB Partners, L.P. +5Other | BuyCommon Stock, par value $0.001 per share | 100.0K | $1.69 | $169.0K | 244.8K |
| Nov 21, 2024Form 4 | MANCHESTER MANAGEMENT CO LLC +4Chief Executive Officer | BuyCommon Stock, par value $0.001 per share · indirect | 166.7K | $1.50 | $250.0K | 3.28M |